NDASUBCUTANEOUSSOLUTIONPriority Review
Approved
Dec 2024
Lifecycle
Growth
Competitive Pressure
0/100
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TRYNGOLZA (olezarsen sodium) is a subcutaneous antisense oligonucleotide approved by the FDA on December 19, 2024. The mechanism of action and specific indications have not been disclosed in available data, but the autoinjector formulation suggests a chronic disease requiring patient self-administration. This represents Ionis Pharmaceuticals' entry into a growing segment of RNA-based therapeutics.
Growth8.0 years to LOE
Early-stage growth product with no established market share; commercial team building and patient awareness programs will be critical near-term priorities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
TRYNGOLZA represents an early-stage growth opportunity within Ionis' RNA platform, offering career visibility in a newly launched specialty product with limited competitive pressure. Roles will focus on market development, payer engagement, patient education, and establishing market presence in what appears to be a novel or underserved indication.
Brand ManagerMedical Science Liaison
Worked on TRYNGOLZA (AUTOINJECTOR) at Ionis Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.